Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Metoprolol Succinate. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Metoprolol can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Metoprolol can be decreased when combined with Abiraterone.
Level 1 evidence
Acarbose
The therapeutic efficacy of Acarbose can be increased when used in combination with Metoprolol.
Level 1 evidence
Acebutolol
Metoprolol may increase the arrhythmogenic activities of Acebutolol.
Level 1 evidence
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Metoprolol.
Level 1 evidence
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Metoprolol.
Level 1 evidence
Acetylcholine
The risk or severity of adverse effects can be increased when Metoprolol is combined with Acetylcholine.
Level 2 evidence
Acetylsalicylic acid
Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol.
Level 1 evidence
Adalimumab
The metabolism of Metoprolol can be increased when combined with Adalimumab.
Level 1 evidence
Adenosine
Metoprolol may increase the arrhythmogenic activities of Adenosine.
Level 1 evidence
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Metoprolol.
Level 1 evidence
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Metoprolol.
Level 1 evidence
Enter your NPI to unlock 7 major interactions for Metoprolol Succinate
Metoprolol Succinate has 1129 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Metoprolol Succinate has 74 major, 466 moderate, and 589 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Metoprolol Succinate. Always confirm against the full prescribing information.